Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Pfaller

Showing results (231-240 of 542) with videos related to

Pageof 55
Sort By:
Diagnostic Microbiology and Infectious Disease|May 6, 2003
In vitro susceptibility testing of filamentous fungi: comparison of Etest and reference M38-A microdilution methods for determining posaconazole MICsM A Pfaller, S A Messer, L Boyken, et al.
Journal of Clinical Microbiology|September 1, 1990
Vancomycin resistance in Staphylococcus haemolyticus causing colonization and bloodstream infectionL A Veach, M A Pfaller, M Barrett, et al.
Diagnostic Microbiology and Infectious Disease|June 23, 2000
In vitro activity of selected cephalosporins and erythromycin against staphylococci and pneumococci isolated at 38 North American medical centers participating in the SENTRY Antimicrobial Surveillance Program, 1997-1998R N Jones, S G Jenkins, D J Hoban, et al.
Archives of Internal Medicine|October 1, 1989
Risk factors for hospital-acquired candidemia. A matched case-control studyS B Wey, M Mori, M A Pfaller, et al.
Antimicrobial Agents and Chemotherapy|June 12, 2019
<i>In Vitro</i> Activity of APX001A (Manogepix) and Comparator Agents against 1,706 Fungal Isolates Collected during an International Surveillance Program in 2017M A Pfaller, M D Huband, R K Flamm, et al.
Antimicrobial Agents and Chemotherapy|September 19, 2000
In vitro pharmacodynamic characteristics of nystatin including time-kill and postantifungal effectS M Gunderson, H Hoffman, E J Ernst, et al.
Journal of Clinical Microbiology|January 1, 1997
Lot-to-lot variability of antibiotic medium 3 used for testing susceptibility of Candida isolates to amphotericin BM Lozano-Chiu, P W Nelson, M Lancaster, et al.
Journal of Clinical Microbiology|May 28, 2010
In vitro activity of anidulafungin and other agents against esophageal candidiasis-associated isolates from a phase 3 clinical trialM A Pfaller, R Hollis, B P Goldstein, et al.
Clinical Chemistry|July 1, 1982
Heparin interferes with the radioenzymatic and homogeneous enzyme immunoassays for aminoglycosidesD J Krogstad, G G Granich, P R Murray, et al.
Journal of Clinical Microbiology|July 1, 1996
Multisite reproducibility of the Etest MIC method for antifungal susceptibility testing of yeast isolatesM A Pfaller, S A Messer, A Bolmström, et al.
Pageof 55

Showing results (231-240 of 542) with videos related to

Sort By:
Pageof 55
Diagnostic Microbiology and Infectious Disease|May 6, 2003
In vitro susceptibility testing of filamentous fungi: comparison of Etest and reference M38-A microdilution methods for determining posaconazole MICsM A Pfaller, S A Messer, L Boyken, et al.
Journal of Clinical Microbiology|September 1, 1990
Vancomycin resistance in Staphylococcus haemolyticus causing colonization and bloodstream infectionL A Veach, M A Pfaller, M Barrett, et al.
Diagnostic Microbiology and Infectious Disease|June 23, 2000
In vitro activity of selected cephalosporins and erythromycin against staphylococci and pneumococci isolated at 38 North American medical centers participating in the SENTRY Antimicrobial Surveillance Program, 1997-1998R N Jones, S G Jenkins, D J Hoban, et al.
Archives of Internal Medicine|October 1, 1989
Risk factors for hospital-acquired candidemia. A matched case-control studyS B Wey, M Mori, M A Pfaller, et al.
Antimicrobial Agents and Chemotherapy|June 12, 2019
<i>In Vitro</i> Activity of APX001A (Manogepix) and Comparator Agents against 1,706 Fungal Isolates Collected during an International Surveillance Program in 2017M A Pfaller, M D Huband, R K Flamm, et al.
Antimicrobial Agents and Chemotherapy|September 19, 2000
In vitro pharmacodynamic characteristics of nystatin including time-kill and postantifungal effectS M Gunderson, H Hoffman, E J Ernst, et al.
Journal of Clinical Microbiology|January 1, 1997
Lot-to-lot variability of antibiotic medium 3 used for testing susceptibility of Candida isolates to amphotericin BM Lozano-Chiu, P W Nelson, M Lancaster, et al.
Journal of Clinical Microbiology|May 28, 2010
In vitro activity of anidulafungin and other agents against esophageal candidiasis-associated isolates from a phase 3 clinical trialM A Pfaller, R Hollis, B P Goldstein, et al.
Clinical Chemistry|July 1, 1982
Heparin interferes with the radioenzymatic and homogeneous enzyme immunoassays for aminoglycosidesD J Krogstad, G G Granich, P R Murray, et al.
Journal of Clinical Microbiology|July 1, 1996
Multisite reproducibility of the Etest MIC method for antifungal susceptibility testing of yeast isolatesM A Pfaller, S A Messer, A Bolmström, et al.
Pageof 55